Atlas Trials

Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.

Clinical trial NCT00417820 · COMPLETED

Trial details

NCT number
NCT00417820
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Psoriasis
Start date
2006-11-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.